Central Washington University

ScholarWorks@CWU
All Master's Theses

Master's Theses

Spring 2018

Modeling the Psychiatric Aspects of Polycystic Ovary Syndrome
and Induced Stress
Danielle Peecher
Central Washington University, peecherd@cwu.edu

Follow this and additional works at: https://digitalcommons.cwu.edu/etd
Part of the Biological Psychology Commons, and the Biology Commons

Recommended Citation
Peecher, Danielle, "Modeling the Psychiatric Aspects of Polycystic Ovary Syndrome and Induced Stress"
(2018). All Master's Theses. 948.
https://digitalcommons.cwu.edu/etd/948

This Thesis is brought to you for free and open access by the Master's Theses at ScholarWorks@CWU. It has been
accepted for inclusion in All Master's Theses by an authorized administrator of ScholarWorks@CWU. For more
information, please contact scholarworks@cwu.edu.

MODELING THE PSYCHIATRIC ASPECTS OF POLYCYSTIC OVARY
SYNDROME AND INDUCED STRESS

A Thesis
Presented to
The Graduate Faculty
Central Washington University

In Partial Fulfillment
of the Requirements for the Degree
Master of Science
Experimental Psychology

by
Danielle Leigh Peecher
May 2018

CENTRAL WASHINGTON UNIVERSITY
Graduate Studies

We hereby approve the thesis of

Danielle Leigh Peecher

Candidate for the degree of Master of Science

APPROVED FOR THE GRADUATE FACULTY

______________

_________________________________________
Dr. Kara Gabriel, Committee Chair

______________

_________________________________________
Dr. April Binder

______________

_________________________________________
Christopher Beeman

______________

_________________________________________
Dean of Graduate Studies

ii

ABSTRACT

MODELING THE PSYCHIATRIC ASPECTS OF POLYCYSTIC OVARY
SYNDROME AND INDUCED STRESS
by
Danielle Leigh Peecher
May 2018

Polycystic ovary syndrome (PCOS) is an endocrine disorder in women that is
characterized by excess testosterone and is associated with increased risk of infertility.
Women with PCOS also show higher rates of depression and anxiety. Modeling PCOS in
mice via administration of dihydrotestosterone (DHT) results in physiological alterations
that are consistent with the physiological symptoms of PCOS in women. While some
studies have investigated behavioral changes in PCOS mouse models, findings have
varied. Thus, the current research examined whether a PCOS model with an additional
stress factor resulted in behavioral changes. To create a stress condition, subjects were
implanted with corticosterone (CORT) pellets to model the complex interaction of stress
and PCOS on depression- and anxiety-like behavior. Data analysis for depression-like
behavior on the forced swim test showed a significant main effect of time, with subjects
spending more time immobile across the 5-minute test, F(4, 108) = 104.43, ps < .001.
Anxiety-like behavior on the elevated zero maze showed a significant time x prenatal
treatment interaction, F(4, 108) = 2.71, p = .034. The hypothesis that the prenatal PCOS
model in conjunction with the stress condition would better model the human condition
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and result in behavioral alterations was only partially supported. These findings are an
important step toward understanding the intersection of stress, mental health, and PCOS
for the approximately five million women in the United States with this disorder.
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CHAPTER I
INTRODUCTION
Of endocrine disorders in reproductive-aged women, polycystic ovary syndrome
(PCOS) is the most often diagnosed (Yu, Hao, Wang, Shen, & Kang, 2016). PCOS is a
disorder associated with metabolic, reproductive, and hormonal changes. Many negative
health outcomes have been associated with PCOS, including infertility, obesity, insulin
resistance, and an increased risk of diabetes (Ressler, Grayson, Ulrick-Lai, & Seeley,
2015). Other common symptoms of PCOS include irregular menstrual cycles, increased
levels of the hormone testosterone, and ovarian cysts (as cited in Yu et al., 2016). As will
be discussed in depth in the follow sections, PCOS in women is often associated with
higher than normal rates of psychiatric illness. As a result, understanding the connection
between PCOS as a biological disorder and its psychological components is crucial. The
etiology for women with PCOS developing psychological disorders is currently unclear.
Research on how anxiety, depression, and other mental disruptions are related to PCOS is
important for both medical and psychological fields (Rassi et al., 2010).
The purpose of the current research was to induce a prenatal model of PCOS in
rodents to understand the physiology and psychiatric components of the disorder. In
addition, a factor of stress was added to attempt to better model the human condition and
understand the complexities of PCOS. The hypothesis that androgen elevation would
produce significant anxiety-like and depression-like behaviors, as measured with mouse
models for anxiety and depression, was examined. Utilizing behavioral models for
anxiety and depression with the prenatal mouse model—we hoped to identify possible
effects of PCOS and androgen elevation in offspring. Overall, answering questions
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related to PCOS and the development of psychiatric illness is necessary for treatment and
better understanding of the disorder.
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CHAPTER II
LITERATURE REVIEW
Physiology of PCOS
Hyperandrogenism is a medical condition that creates excess testosterone
hormone in females and is a factor in PCOS. Increased testosterone is also related to
ovarian and reproductive disruptions (Rasgon et al., 2005). Testosterone is predominately
associated with masculinity and high testosterone in women tends to increase facial hair,
aggression, muscle mass, and general masculine features. Hahn and colleagues (2005)
studied a sample of 120 women with PCOS and a demographic-matched control group
and found those with PCOS had significantly higher levels of serum testosterone.
Another study, using a hormone assay, again found increased total testosterone levels in
PCOS women (Barth, Field, Yasmin, & Balen, 2010). Amiri and colleagues (2014)
examined metformin and flutamide in treating PCOS and measured testosterone levels
along with hirsutism scores (i.e., abnormal hair growth and facial hair) that appeared to
correlate with increased testosterone. Therefore, hyperandrogenism functions in PCOS by
increasing testosterone levels, which may associate with decreased fertility and
manifestations of masculine characteristics or behaviors.
An example of reproductive disruptions includes the increased risk of infertility in
women with PCOS. According to a PCOS review article, infertility often results from the
lack of ovulation (i.e., anovulation) in respective women (Goodarzi, Dumensic,
Chazenbalk, & Azziz, 2011). An important longitudinal cohort study examined selfreports on infertility, infertility hormone treatments, and regularity of ovulation in women
with and without PCOS (Joham, Teede, Ranasinha, Zoungas, & Boyle, 2015). According
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to participants’ reports, 72% and 16% of women with PCOS and without, respectively,
experienced infertility. Infertility rates were significantly higher in women with PCOS;
however, Joham and colleagues (2015) discussed the limitation that these infertility rates
only come from women who have attempted pregnancy, which may underestimate actual
infertility rates. As proposed by Tian, Shen, Lu, Norman, and Wang (2007), infertility in
women with PCOS also interacts with insulin resistance as supported by their findings of
a 30.8% risk for spontaneous abortion in women with PCOS and a 47.8% for those only
with insulin resistance. Described by Tian et al., insulin resistance is predicted to mediate
the relationship of obesity, PCOS, and spontaneous abortion. More specifically, both
obese women and women with PCOS are at risk for insulin resistance. Women with
PCOS have higher levels of obesity and, thus, these factors contribute to difficulty in
achieving or maintaining a pregnancy.
Beyond infertility, insulin resistance also increases the risk of diabetes in women
with PCOS. Although the exact prevalence of Type 2 diabetes in women with and
without PCOS varies across studies (Moran, Misso, Wild, & Norman, 2010), Talbott et al.
(2007) documented that 12.8% of women with PCOS had Type 2 diabetes, significantly
more than the 3.6% of women without PCOS. Importantly, in a review by Ressler et al.
(2015), obesity was reported to be prevalent in PCOS populations with rates ranging
between 61 to 76% of those in diagnosed samples (Ching, Burke, & Stuckey, 2007;
Glueck et al., 2005). Animal research indicates that obesity can intensify PCOS
symptomology with rats fed a high fat diet having higher insulin resistance compared to
rats on a low fat diet (Ressler et al., 2015). Unfortunately, higher insulin resistance may
be an inescapable symptom of PCOS because rats modeling PCOS that were fed a low fat
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diet still exhibited insulin resistance, just to a lesser extent than did rats modeling PCOS
that were fed a high fat diet. As these researchers concluded, dietary changes may not be
effective in improving insulin resistance in women with PCOS.
PCOS is a heterogeneous condition and, therefore, it has been difficult for
clinicians and researchers to understand all of its associated metabolic, reproductive, and
hormonal changes, making consistent diagnostic criteria difficult to establish. For
example, March et al. (2010) utilized three possible PCOS criteria, from the National
Institutes of Health (NIH), the Rotterdam, and the Androgen Excess Society (AES), to
determine which produced a higher estimate of the prevalence of the disease. The results
yielded prevalence rates of PCOS ranging from 8.7% to 11.9% using NIH and AES
criteria, respectively. The Rotterdam criteria provided a prevalence rate of 10.2% (March
et al., 2010). More research on PCOS is clearly needed to improve diagnostic criteria as
well as to enhance research on treatment options.
PCOS and Psychiatric Disorders
Often mental illness is dually diagnosed with other health concerns. For example,
depression is often associated with other mental health disorders or medical conditions,
and PCOS’s wide variety of symptoms includes psychiatric disturbances (e.g., Yu et al.,
2016). Determining how anxiety, depression, and other potential psychological,
behavioral, or cognitive changes are related to PCOS is important for both medical and
psychological fields (Rassi et al., 2010). Rassi and colleagues (2010) found that 55.9%
of sampled women with PCOS were also diagnosed with a psychiatric disorder. The most
commonly diagnosed disorders in that sample were depression (26.4%) and anxiety
(9.7%). Jedel and colleagues (2010) used a small sample of 60 women, 30 of whom were
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diagnosed with PCOS and found self-reported anxiety on the Brief Scale for Anxiety to
be significantly higher in the PCOS group. Another study found that depression, as
measured by a psychiatrist, had a 2.93% higher prevalence in women with PCOS
compared to controls (Hung et al., 2014). Thus, the research indicates that women with
PCOS are more likely to exhibit depression or other mood disorders, but the etiology of
psychiatric disorders in PCOS remains unclear.
Investigating the connection between PCOS and depression, Yu et al. (2016)
measured depressive-like behaviors and changes in monoamines (i.e., serotonin,
dopamine, norepinephrine) in a PCOS mouse model that used androgen treatment to
induce PCOS-like symptoms and found significantly higher levels of serotonin in the
hippocampus, striatum, hypothalamus, and dorsal ralph nucleus brain regions in treated
mice compared to controls. Accordingly, it is possible that depression and other
psychological disorders develop in PCOS due to androgen excess and subsequent
biochemical changes in the brain.
Thus, while the hyperandrogenism associated with PCOS may underlie both the
physical and psychological symptoms of the disorder, another potential pathway in the
etiology of psychological disorders in women with PCOS may be that coping with the
physical symptoms of PCOS, such as infertility and obesity, leads to psychological
disorders such as anxiety and depression. Supporting such a possibility is research by
Annagur et al. (2013) who reported that testosterone levels were not significantly
different in those with or without depression and PCOS. Cwikel, Gidron, and Sheiner
(2004) suggested that stressors associated with infertility manifest as depression or
anxiety in women with PCOS, and Hahn et al. (2005) found that women with PCOS

6

reported decreased quality of life in physical, emotional, social, and psychological areas.
In contrast, a meta-analysis of research on depression and PCOS found that, although
there was an increased risk of depression in women with PCOS, that risk was
independent of obesity (Dorkas, Clifton, Futterweit, & Wild, 2011). Regardless of the
mechanism of action, PCOS is clearly interconnected with mood disturbances and,
ultimately, affects the quality of life for those living with the disease. However,
understanding the mechanism of action and how the physical symptoms of PCOS are
related to psychological disorders is crucial in developing and investigating potential
treatments for anxiety and depression in women with PCOS.
Stress, Psychological Disorders, and PCOS
In attempting to explain the relationship between PCOS and depression, Benson
et al. (2009) suggested that stress response differences in women with PCOS might
contribute to the observed increased rates of depression among patients. In that study,
women with PCOS had significantly increased heart rate and cortisol levels when stress
was induced via a public speaking task. It remains important to understand this
interconnection between stress, physiological changes, and mental health.
Many risks factors and processes of chronic stress are related to and intertwined
with the etiology of mental illness. It is accepted among mental health and biological
fields that depression is caused by a combination of biopsychosocial factors (e.g., Dinan,
1994; Duman, Aghajanian, Sanacora, & Krystal, 2016; Menke & Binder, 2014; Nester,
2014). For example, studies in epigenetics identify genetic risk factors for depression
being ‘turned-on’ in reaction to stress (Nester, 2014) potentially through the actions of
the glucocorticoid stress hormones, cortisol in humans and corticosterone in rodents.
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Cortisol is involved in acute and chronic stress responses and is the end product of the
hypothalamic-pituitary-adrenal (HPA) axis, which responds to physiological and
psychological stressors with increased plasma cortisol levels (Varghese & Brown, 2001).
Physiological effects of cortisol include altering “…basal processes such as fat and
glucose, metabolism, blood pressure, inflammatory, and immune responses…” (as cited
in Staufenbiel et al., 2013, p. 1221). While sympathetic arousal reallocates immediate
energy resources to systems designed to enhance survival during stress (i.e., fight-orflight), cortisol continues the reallocation of energy away from non-crucial body
functions during longer acute stressors or under chronic stress (Boersma & Tamashiro,
2015). Importantly, elevated cortisol levels are part of an inhibitory feedback loop in
which cortisol crosses the blood-brain barrier, binds to glucocorticoid receptors in the
hypothalamus, and inhibits further HPA activity, bringing the stress response to an end
and restoring homeostasis.
Notably, cortisol may play a role in some psychological disorders. For example,
neuroendocrine studies have identified a relationship between decreased serotonin and
increased cortisol in some cases of depression (Dinan, 1994). Graeff, Guimaraes, De
Andrade, and Deakin (1996) report that by targeting serotonin receptors (i.e.,
pharmaceutically) they were able to increase public speaking anxiety in humans as well
as anxiety-like behaviors in mice. Thus, Graeff et al. reduced serotonin using antagonist
drugs and, subsequently, may have increased cortisol. Dinan (1994) reviewed the
complexities of increased levels of cortisol binding to glucocorticoid receptors in limbic,
hippocampal, and hypothalamic brain regions; and concluded, “If this hypothesis is
correct … these abnormalities in central monoamines are primary and induce secondary
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endocrine disturbance” (Dinan, 1994, p. 369). As described, glucocorticoid receptors in
these regions (i.e., limbic, hippocampal, and hypothalamic) link cortisol to monoamine
changes and, possibly, psychological disorders. Connections between cortisol, HPA
dysfunction, and depression have been demonstrated by the dexamethasone suppression
test (Carroll, 1982). Dexamethasone is a synthetic cortisol that crosses the blood-brain
barrier and should reduce endogenous cortisol levels via inhibition of further HPA
activity. However, in a proportion of individuals with depression, cortisol levels remain
elevated following dexamethasone administration, suggesting neuroendocrine
dysfunction in depression.
HPA and Hypothalamic-Pituitary-Gonadal (HPG) Interactions
Cortisol release from the adrenal gland in response to stress reallocates energy to
prepare for physical exertion, and part of that process alters HPG axis activity. Reviewing
the connection between the HPA and HPG axis, Whirledge and Cidlowski (2010)
describe three contributions of the HPA axis onto the HPG system. First off, the
hypothalamus, when stimulated by excess cortisol, decreases production of gonadotropinreleasing hormone (GnRH), which is an initial step in HPG activation. Secondly,
Whirledge and Cidlowski reported that the pituitary gland can inhibit secretion of
luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which together are
responsible for ovulation and reproductive processes. The third interaction is the gonadal
aspect and decreased formation of proper hormones and gamete production (i.e., estrogen
and oocytes). Divyashree and Yajurvedi (2016) reviewed the impact of stress-induced
HPA activity on HPG function, finding significant increases in adrenal gland weight and
serum cortisol concentrations associated with decreased estrous cycles and decreased
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ovary weight following exposure to eight weeks of stress in rats. Thus, reductions in
gonadal functions have been documented in response to chronic stress, and such
pathways may contribute to exacerbation of HPG disruptions in PCOS, given the
psychological and physiological stress associated with infertility and anovulation.
PCOS and Stress. Considering the marked effects on androgen hormone levels,
reproductive functions, and metabolic systems in PCOS, it may be possible to draw
connections between HPG alterations and stress systems. Supporting the connection
between stress and PCOS, Ressler et al. (2015) measured HPA activation in a mouse
model of PCOS by a novel environment stressor. Surprisingly, Ressler et al. found that,
in novel environment tests, PCOS mice had lower corticosterone responses than did
controls. However, these mice also demonstrated anxiety-like behavior in an elevated
plus maze; a behavioral finding that would typically correlate with increased
corticosterone levels. Measuring corticosterone levels in animal models becomes
important when attempting to parse out these discrepancies. These results point to
possible differences between PCOS and controls in processing or responding to stressful
events.
Unfortunately, as previously noted, variations of physical symptoms in women
with PCOS have made it difficult for researchers to identify a common etiology (Abbott,
Tarantal, & Dumesic, 2009). Additionally, psychological symptoms such as anxiety and
depression may stem from underlying physiological differences in HPA and/or HPG
systems in women suffering from the disorder or from stressors caused by PCOS
symptomology (i.e., infertility). Fortunately, animal models of PCOS may allow
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researchers to disentangle the potential causes of psychological disorders associated with
PCOS.

Animal Models
Biological Models. Animal models, especially in rodents, are widely used in
PCOS research and, while these models all involve androgen administration, they vary in
the timing of that androgen exposure. PCOS models either involve prenatal or
peri/postnatal androgen administration. Thus, prenatal and postnatal PCOS models target
differences in organizational and activational processes in the HPG system, respectively
(Foecking, McDevitt, Acosta-Martinez, & Horton, 2008). For example, androgens can
play an organizational or activational role in “masculinization and defeminization of the
neuroanatomy, behavior, and endocrinology of male rats” (as cited in Foecking et al.,
2008, p. 3). Prenatal models focus on the hypothesis that PCOS, although diagnosed in
women post-puberty, is actually due to differences in hormonal systems that were
organized and established during prenatal development. Roland, Nunemaker, Keller, and
Moenter (2010) state that dysfunction of reproduction in prenatally androgenized (PNA)
mice relates to “…androgen programming of the reproductive axis…” (p. 221).
Therefore, prenatal models alter pathology earlier in development than do postnatal
models, changing the organization structure of pathways that will then be activated in
puberty.
Only one study to date directly compares the effects of prenatal and postnatal
mouse PCOS models involving androgen administration and focuses on physiological
phenotypes, including ovarian weights and cycles, insulin resistance, and adipose tissue
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changes (Caldwell et al., 2014). Caldwell and colleagues (2014) found that mice in a
postnatal PCOS model underwent fewer estrous cycles in two weeks than did those in a
prenatal PCOS model. In contrast, mice in a prenatal PCOS model exhibited a higher
percentage of unhealthy ovarian follicle cells than did those in a postnatal PCOS model.
Thus, either postnatal or prenatal models can be utilized when modeling PCOS
phenotypes and, as previously mentioned, organizational and activational androgen
administration is the most critical distinction between pre- and postnatal PCOS models.
Other physiological changes that are important to metabolic and endocrine
changes associated with PCOS include vaginal opening and anogenital distance measures.
Marking the beginning of the estrous cycle, vaginal opening typically occurs at the fifth
postnatal week (Rodriguez, Araki, Khatib, Martinou, & Vassalli, 1997); however, this
opening has been found to occur earlier in some PNA models of PCOS (Roland et al.,
2010). Rodriguez et al. (1997) found that mouse models would undergo vaginal opening
earlier if they were exposed to an estrogen precursor. It seems, then, that hormone
regulation is important for vaginal opening. Prenatal models of PCOS have not reported
vaginal opening as a standard measure. Schober, Dulabon, Martin-Alguacil, Kow, and
Pfaff (2006), in a study unrelated to PCOS, reported vaginal fusion in young girls and
describe it as fusion of the labia together and red tissue surrounding the vagina. Schober
et al. also discussed the function of lower levels of estrogen at birth playing a role in the
vaginal fusion event. Connecting this concept to the study done by Rodriguez and
colleagues, if PNA mice have elevated testosterone and lower levels of estrogen, then, the
lack of vaginal opening is a reasonable outcome given that reproductive hormone
dysfunction could result in vaginal fusion. Cases of vaginal fusion may be underreported
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in PCOS animal models. In addition, anogenital distance, which is normally longer in
males, is a measure that increases in women exposed to androgens during in utero
development (Wu, Zhong, Chen, Zheng, Liao, & Xie, 2017). One prenatal PCOS rat
model found that PNA-treated subjects had longer anogenital distance (Wu et al., 2010).
Because PCOS is characterized by increased testosterone in females, measuring
anogenital distance has become a validation measurement for the model. Both vaginal
opening and anogenital distance are sensitive physiological metrics for reproductive
hormone changes.
PCOS models also vary in their utilization of testosterone and related hormones to
simulate different processes of the disease. Caldwell et al. (2014) identified “4 distinct
hyperandrogenized models,” that include “androgens, estrogens, aromatase inhibitors,
antiprogestines, changes in light exposure, and genetic manipulations” (p. 3147).
Testosterone, in healthy women, is processed by the enzyme aromatase into estrogen;
thus, estrogen and aromatase levels are typically higher in females (Goodarzi et al., 2011).
Interrupting the process of converting testosterone to estrogen is accomplished by using
dihydrotestosterone (DHT) or dehydroepiandrosterone (DHEA) derivatives that remain
as testosterone. As a reminder, serum testosterone levels are higher in women with PCOS.
The purpose of these models is to alter biological processes and produce excess
androgens to simulate PCOS.
Walters, Allan, and Handelsman (2012) summarized the effects of DHEA on
metabolic and reproductive symptoms. DHEA is similar to DHT in that both are
derivatives of testosterone and will not convert to estrogen in women. The authors
suggested that recent research has utilized DHEA models for studying “acyclicity,
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abnormal maturation of ovarian follicles, and anovulation” (p. 1). DHEA is primarily
used in postnatal models. For example, Walters et al. (2012) reviewed the literature on
several postnatal DHEA rodent models, and found these studies consistently produced
irregular or acyclic estrus cycles and ovarian cysts. Another review of PCOS animal
models emphasized that DHEA, as a long-term postnatal treatment, is “the best approach
to simulate the breadth of reproductive, endocrine, and metabolic features of human
PCOS” (Caldwell et al., 2014, p. 3155). In regards to DHEA, Caldwell et al. found
effects on androgen levels to approach higher levels in the DHEA postnatal model
compared to DHEA in the prenatal model. As mentioned previously, Caldwell and
colleagues (2014) studied DHEA and DHT in both pre- and postnatal models.
The other commonly studied model for simulating excess androgen uses DHT, a
derivative of testosterone. Unlike DHEA, which has mostly been examined in postnatal
models, DHT has been examined in both pre- and postnatal models. Caldwell et al.
(2014) demonstrated that DHT animal models resulted in fewer completed estrous cycles,
reduced ovary weight, and a significantly higher percentage of unhealthy follicle cells.
DHT has also been found to produce features of ovarian morphology similar to PCOS
with unhealthy follicles and atretic cyst-like formations (Caldwell et al., 2014).
Additionally, DHT in prenatal models mimics “androgen excess… of human PCOS”
closely (Caldwell et al., 2014, p. 3156). Thus, based on the current literature, DHT is
supported as a prenatal model of PCOS.
In conclusion, both pre- and postnatal models have been used to simulate PCOS
physiological phenotypes in animals. Recently, Yu and colleagues (2016) studied brain
structure and monoamines in relation to the effects of androgens (i.e., mimicking PCOS)
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on depression and mood disorders. Nonetheless, research on the relationship between
psychological disorders and PCOS is limited to only a few studies. In prenatal models,
researchers have historically examined biological PCOS effects, but studies on the
psychological symptoms of PCOS have been published recently. Determining the
interplay between these areas of symptomology is important to increase PCOS
knowledge and to further understand PCOS models.
Behavioral Models. In order to understand the impacts of PCOS in humans,
researchers have used behavioral models to observe emotional and psychological distress
in animal subjects. Animal models such as the elevated zero maze (EZM) and forced
swim test have predictive validity for research in biomedical fields (Yan, Cao, Das, Zhu,
& Gao, 2010; Bell, Duke, Gilmore, Page, & Begue, 2013). Therefore, pharmaceutical
companies have validated these models of anxiety- and depression-like behavior to
investigate potential clinical anxiolytic and antidepressant drug efficiency. Such
behavioral models are short tests (e.g., 5- or 15-minute intervals) and consist of coding
inactivity or activity changes across the time-period (Castagne, Moser, Roux, & Porsolt,
2011). For example, forced swim tests in which time spent struggling in a small, roomtemperature pool of water is measured, have been validated for their ability to predict
clinical efficacy of antidepressant medications, namely fluozetine, in humans.
Antidepressant efficacy in clinical trials is correlated with decreased time spent immobile
in the forced swim apparatus in mice that received a single acute pre-administration of
the drug (Page, Detke, Dalvi, Kirby, & Lucki, 1999).
It is important to note that these behavioral models for anxiety- and depressionlike behaviors also show face validity (i.e., giving up and not swimming or struggling on
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the forced swim test resembles hopelessness) as well as pharmaceutical predictive
validity. For example, the EZM is a circular maze consisting of two open and two closed
sections. Rodents appear to prefer the closed sections and, under standard conditions,
spend more time in those sections. Time spent in the open sections is interpreted to reflect
decreased anxiety-like or fear-like behavior; an interpretation further supported by
findings that anxiolytic medications increase the percentage of time spent in open-arms of
the maze (Shepherd et al., 1994). Other behavioral changes on the EZM which include
exploratory behavior such as head-dips, rearing, and stretched attend posture are also
sensitive to anxiolytic manipulation (Molewijk, van der Poel, & Oilvier, 1995). Given
that behavior on the EZM and forced swim test changes in predictable ways in response
to anxiolytic and antidepressants agents, respectively, these models are commonly used
as measures of anxiety and depression.
In investigating behavioral changes in a prenatal PCOS model (i.e., PNA mice),
Yu et al. (2016) utilized the forced swim and tail suspension test to observe “depressionlike behavior” (p. 1) and the open field test to investigate activity and anxiety-like
behavior. Yu et al. found that PCOS animals exhibited significantly increased immobility
on both the forced swim and tail suspension tests, which is interpreted as depression-like
behavior. On the open field test, PNA mice had significantly lower activity levels.
Therefore, these findings indicate that animal models of PCOS may show behavioral
changes, including lower activity levels and higher depression-like behavior.
Another related study administered DHT in a rat prenatal model examined
anxiety-like behavior in the offspring (Hu et al., 2015). These researchers found a
significant decrease in activity in the open arms of the EZM in PCOS animals compared
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to controls. Likewise, Ressler and colleagues (2015) discovered mice treated with DHT
postnatally exhibited anxiety-like behavior represented by decreased time spent in the
open arms of an EZM. Additionally, this same study found increased immobility for PNA
mice on a forced swim test. Taken together, these findings suggest that animals exposed
to treatments designed to model PCOS show alterations in anxiety- and depression-like
behaviors: however, such investigations have not been widespread nor have they
considered the additional effects of stress on behavior.
Order effects. Behavioral test history and carryover effects in test batteries have
been previously reported in animal research. The prevailing rule of thumb has been that
less invasive tests should be conducted first, followed by more invasive testing (i.e.,
Blokland et al., 2012; McIlwain, Merriweather, Yuva-Paylor, & Paylor, 2001; Voikar,
Vasar, & Rauvala, 2004). It is important to understand the differences between test naive
and experienced mice when running behavioral tests. Voikar, Vasar, & Rauvala (2004)
found that naive C57BL/6J mice took a significant shorter time to enter open areas of an
elevated plus maze and spent a longer amount of time in open arms. The elevated plus
maze is similar to the EZM and this finding is important for interpreting the results of the
current research. Whereas these carryover effects may occur in the elevated plus maze,
McIlwain et al. (2001) found that carryover effects were test dependent, limiting
generalizations across tests. In considering the possibility of carryover effects and test
history, the current research followed the concept of using the least invasive test first,
followed by the more invasive test.
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Animal Models and Stress
As previously mentioned, acute stress is temporary, whereas chronic stress is
more prolonged and, often, more pronounced than normal day-to-day stress functions. In
humans, the nature, number, and persistence of stressors are associated with the onset and
relapse of psychological disorders as well as the intensity of symptomology
(Schneiderman, Ironson, & Siegel, 2005). However, stress responses are also adaptive
and serve as a biological mechanism for regulating basic bodily processes and fight-orflight fear responses (Mastorakos, Pavlatou, & Mizamtsidi, 2006). One interesting study,
found that chronic stress exposure had physiological changes that were similar to a PCOS
phenotype (Divyashree & Yajurvedi, 2016). In this model, after 12 weeks of stress
exposure, the stress condition mice showed lower body weights, increased adrenal gland
weights, and elevated serum corticosterone. There are multiple physiological measures
that can be taken to validate a stress model, and these models can also be created in
various ways.
Examining stress in animal models can take various forms. One such example
uses physical restraint to induce stress. Divyashree and Yajurvedi (2016) recently used
an “open-ended cylindrical glass restrainer” and forced swim test to induce chronic stress
in rat subjects (p. 766). In that study, chronic stress resulted in increased adrenal gland
activity, cortisol concentration, and decreased body weight after eight weeks of stress.
Similar studies have used other forms of stress models, including but not limited to coldrestraint exposure, physical restraints, and social defeat stress (Divyashree & Yajurvedi,
2016; Golden, Covington, Berton, & Russo, 2011).
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Such physical stressors may represent environmental stress, however, such studies
have yielded conflicting results. For example, Golden and colleagues (2011) used a
social defeat paradigm that produced stress-related behavior as measured by social
interaction and avoidance; however, the authors suggested they might have, instead,
modeled depression-like behavior. Even in human research, the concept of stress as a
scientific idea continues to evolve as researchers acknowledge that stress does not exist
as a uniform response to challenges to homeostasis but that, in fact, different stressors
induce difference patterns of sympathetic and HPA activity (Goldstein & Kopin, 2009).
Thus, when investigating the impact of cortisol and/or HPA activity, one possible remedy
to inconsistent results and variations in models of stress would be to use cortisol or
corticosterone pellets to induce a steady-state elevation in glucocorticoids.
Hermann and colleagues (2009) compared the effectiveness of administering
corticosterone with subcutaneous injection, implantation of hormone-releasing pumps,
and implantation of slow-release pellets. Administering corticosterone via pellets
appeared to maintain consistent plasma levels with rapid increases in corticosterone
within hours of administration. However, these authors discussed the need to replace
corticosterone pellets after 7 and 14 days to maintain heightened and consistent
corticosterone levels. Importantly, Hermann and colleagues measured corticosterone
levels on a daily basis, and demonstrated a narrow range of levels between subjects (i.e.,
1200 and 1400 μg/L) with low variation between subjects. Thus, in regards to evaluating
the physiological and behavioral effects of HPA activation, using corticosterone pellets
provides the most control and consistency over corticosterone levels which may be more
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desirable for reasons of internal validity. As was done by Herrmann et al., it is necessary
to measure serum levels of corticosterone to verify the validity of the treatment.
Hypotheses
The purpose of the current study was to investigate the potential of a mouse
model of PCOS, in particular a model using prenatal administration of DHT, to induce
excessive androgen levels and to examine the physiological and psychological symptoms
associated with PCOS. The impact of elevated corticosterone (CORT) in both PCOS and
control mice was also evaluated. It was hypothesized that PNA mice would show more
anxiety- and depression-like behaviors than prenatal saline mice due to organizational
changes produced by androgen elevation in the prenatal PCOS mouse model. It was
further anticipated that inducing stress-like conditions in mice would produce heightened
anxiety- and depression-like behaviors, but that those effects would be more pronounced
in animals that had been prenatally exposed to androgen (i.e., PNA or PCOS-model mice).
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CHAPTER III
METHODS
Subjects
The current study’s prenatal model of PCOS used C57BL/6J mice because of
their applicability in comparative studies and because C57BL/6J dams are successful
breeders as measured by litter size and survival rates (Weber, Hultgren, Algers, & Olsson,
2016). Additionally, C57BL/6J mice demonstrate moderate baseline activity levels
appropriate for behavioral measures (de Visser, van den Bos, Kuurman, Kas, & Spruijt,
2006). Twenty-four female C57BL/6J mice were obtained from Jackson Laboratory
along with males for breeding purposes. Dams were randomly assigned to the DHT or
saline conditions, with successful pregnancies in 10 and 6 dams, respectively. Breeding
proceeded in two separate rounds. The first round of breeding produced 10 DHT and 12
prenatal saline female offspring. For the second round of breeding, we obtained 11 DHT
and 4 prenatal saline female offspring. The resulting number of subjects for each
experimental condition were: n = 12 (PNA-CORT), n = 9 (PNA-Control), n = 5 (Prenatal
Saline-CORT), and n = 11 (Prenatal Saline-Control). Central Washington University’s
Institutional Animal Care and Use Committee approved all experimental procedures
(Protocol #).
Care and Housing. Animals were housed in climate-controlled (i.e., 75-77o F),
12-hour light/dark cycle rooms. Initial housing and breeding occurred in the Science
Building vivarium at Central Washington University. Animals were pair-housed with
same-sex animals in the same condition in clear polypropylene cages (22.2 x 30.80 x
16.24 cm) and provided with CareFresh bedding (Kaytee Aspen Bedding), Mazuri rodent
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diet chow (6F), and water ad libitum. After weaning and pellet implantation, mice were
transferred to the Department of Psychology vivarium, with conditions matched to the
Science vivarium. The principle investigator was responsible for animal care, including
daily cage checks and weekly cage changing.
Dams and Breeding. Female C57BL/6J mice were used in a time-mating
protocol, which ensured the offspring for testing were born within a two-day period.
Male C57BL/6J mice were paired with a female mouse for two consecutive evenings.
Breeding occurred in the familiar cage of the female. In order to determine gestation date,
dams were checked daily for the presence of copulation plugs; the presence of such a
plug designated day 0 of gestation. Dams delivered pups at day 19.5 to 20.5. Once litters
were produced, the pups remained with their dam until weaning on postnatal day 21
(PN21).
Physiological Measures. Seven days after birth, group weights of female pups
were taken for each treatment group. This method of body weight was continued for
PN14 and PN21. After weaning on PN21, individual weights were taken once a week
until undergoing pellet surgery on PN36. During surgical recovery, female offspring were
weighed daily until behavioral testing. Final weights were taken immediate to euthanasia.
Vaginal openings were checked daily after weaning and until all subjects showed
openings or until surgery, whichever came first. For some subjects, qualitative reports of
vaginal redness were collected. Anogenital distance was measured for all subjects after
euthanasia.
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Materials
PNA Model. At day 0 of gestation, dams were randomly assigned to either the
PNA or saline group. Following a protocol from Caldwell et al. (2014), dams in the PNA
condition received DHT (i.e., 250 μg) prepared in sesame oil, which was administered
subcutaneously in a volume not exceeding 100 μL per injection. Saline was also prepared
in sesame oil and administered in 100 μL injections. The DHT and saline injections were
administered on days 16-18 of pregnancy. The DHT treatment is designed to produce
organizational changes in the dam’s female offspring that result in a mouse model of
PCOS in those offspring.
Stress Model. Female offspring of each litter were randomly assigned to CORT
pellet or a control pellet treatment. CORT pellet preparation followed a published
protocol using low-cost pellets (Sahores et al., 2013). Referring to Sturm, Becker,
Schroeder, Bilkei-Gorzo, and Zimmer (2015), 20 mg of corticosterone was used in the
pellets. Following Sahores et al.’s (2013) protocol, 600 mg corticosterone was mixed
with 3.6 mg of silicone adhesive. Control pellets were made using only silicone adhesive.
CORT pellets were pressed and kept overnight between glass slides. The pellets were,
then, cut into equal 4 mm diameter pieces. Surgery and subcutaneous implantation of
CORT pellets were followed by use of vet bond and a staple to close the wound. Subjects
were allowed seven days of recovery before conducting behavioral tests. In future studies,
serum CORT levels will be measured in subjects to verify this model.
Behavioral Models
Some models for psychological disturbances in mice include the EZM and forced
swim test, which provide operationalized variables of anxiety, depression, and baseline
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activity. Behavioral testing occurred between PN43 to 47 for female offspring. Each
behavioral model measured subject activity in 5 min increments. Subject activity was
recorded using a video camera placed above or across from the apparatus. Trained
observers coded activity of mice after all behavioral testing was complete. To ensure
reliability, scores for each video came from the average of two coders. Scores needed to
be in 70% agreement or higher to be included in the average. If the agreement was below
70%, a third coder’s data were, instead, used in the average calculation. If 70%
agreement was not achieved after the third coder, the average per condition and time
interval was included. To clarify, if a PNA-CORT subjects’ score for minute 1 did not
reach 70% agreement then the average for all other subjects in both PNA and CORT
treatment conditions for that minute was averaged and included in that cell.
EZM. The EZM measures anxiety-like behavior based on the time spent in open
compared to closed areas as well as providing measures of total activity in the form of
total arms entered. Subjects in all four experimental conditions (i.e., PNA-CORT, PNAControl, Prenatal Saline-CORT, Prenatal Saline-Control) underwent the EZM first. The
EZM apparatus was elevated 50 cm off the floor and is an annular maze (e.g., circular).
The maze was 60 cm in diameter and consists of four distinct quadrants. Open quadrants
and closed quadrants, with ~28 cm clear acrylic walls, are opposite each other in the
EZM maze. See Appendix A for an image of the EZM. Mice were placed in the maze for
5 min. Lumens in the open areas were approximately 22 to 40 lux and in the closed areas
were 6 to 10 lux. Movement between closed and open areas and time spent in the open
and closed arms were coded. An entry into an open arm occurred if the mouse crossing
all 4 paws into the open arm. Counting the number of entries into closed and open arms
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followed the same requirement; that all 4 paws needed to cross into the new arm. If mice
spend time mostly in closed areas, this is interpreted as indicative of anxiety-like
behavior. Again, this behavioral model has predictive validity for pharmaceutical drugs,
such as anxiolytics. Each subject was tested on the EZM before testing on the forced
swim apparatus.
Forced swim. As a test of depression-like behavior, subjects in all four
experimental conditions (i.e., PNA-CORT, PNA-Control, Prenatal Saline-CORT,
Prenatal Saline-Control) underwent a forced swim test 24 hr after the EZM. Mice were
placed in a 5000 mL container of room-temperature water. The container was filled with
3500 mL of water so the mouse could not touch the bottom or climb out. See Appendix A
for an image of the forced swim apparatus. Mice naturally can swim; however, they
prefer to escape water. Mice can either choose to swim (e.g., attempt to get out) or float.
Floating behavior is coded as immobility and is taken at face value to resemble
hopelessness behavior (i.e., depression-like behavior). Floating behavior was coded,
resulting in immobility data for each of the 5 min of the test. Floating was determined if
the animal was not propelling through the water and only had minimal paw movements
(i.e., only paw movement to stay above water not to propel it through the water). As
discussed previously, the forced swim test has been validated as a depression-like
behavioral model for testing antidepressant drugs.
Design
PCOS was operationalized in the current experiment by the concept of prenatal
exposure to androgen excess. More specifically, female mice in the experimental group
should have mimicked PCOS symptomology following the prenatal administration of
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DHT (i.e., a testosterone derivative). Body weight measures were collected weekly to
determine percent body weight changes, as other studies have found differences in body
weight in response to DHT or CORT treatment, separately. As mentioned, vaginal
opening determines sexual maturity in female subjects. After euthanasia, anogenital
distance was measured to determine if prenatal exposure to androgen resulted in larger
anogenital distances compared to control subjects.
Measures of depression- and anxiety-like behavior were collected for all subjects
to compare psychological effects of prenatal treatment (i.e., PNA, Prenatal Saline) and
postnatal stress condition (i.e., CORT, Control). Overall, it was expected that mice in the
DHT group would spend less time in the open arms of the EZM (i.e., increased anxietylike behavior) and have higher levels of immobility in the forced swim test (i.e.,
increased depression-like behavior). Each subject completed the EZM and, then, after 24
hr, the forced swim test. As noted, for each test, data were collected for each minute of
the 5 min test to determine if behavioral patterns rather than overall behavior differed
across conditions. Therefore, 2 (PNA, Prenatal Saline) x 2 (CORT, Control) x 5 (1-5 min)
mixed ANOVAs were used to analyze behavior on the EZM and immobility on the FST.
In other words, each behavioral measure followed a repeated measures design of activity
and immobility (i.e., repeated measures were scored at each minute in the interval).
Statistical Analysis
As previously noted, behavioral data consisted of averages from two coders per
video recording. On measures in which coders did not show over 70% agreement, a third
coder’s data were included in the average. Lastly, when 70% was not reached, the
average score for the condition and time interval was included.
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Mixed factor ANOVAs examined the effects of PNA and postnatal CORT
administration on behavioral measures in all subjects. When appropriate, an additional
factor of minute in the test (i.e., 1-5 min) was utilized, for resulting separate 2 (PNA,
Prenatal Saline) x 2 (CORT, Control) x 5 (1-5 min) ANOVAs to analyze time spent in
the open arms of the EZM, total arm entries on the EZM, and immobility on the forced
swim test. As noted, increased time in the open arms is interpreted as decreased anxietylike behavior while increased immobility on the forced swim test is interpreted as
depression-like behavior. Bonferroni correction was used as a post-hoc analysis for all
statistics.
Physiological measures were analyzed using separate independent samples t-tests
or ANOVAs. The physiological measures and analysis included the number of pups born
to each treatment condition dam (independent samples t-test), which was collapsed within
each cage to account of pair housing of dams. Weights before pellet implantation [2
(PNA, Prenatal Saline) x 3 (PN7, PN14, PN21) ANOVA], final weight at the time of
euthanasia [2 (PNA, Prenatal Saline) x 2 (CORT, Control) ANOVA], vaginal opening
[(PNA, Prenatal Saline) ANOVA], and anogenital distance [2 (PNA, Prenatal Saline) x 2
(CORT, Control) ANOVA], were also analyzed. Two analyses were included for vaginal
opening. The first measured the percentage of true vaginal opening in subjects for each
group. The second counted vaginal opening as the first day of the qualitative observation
of red tissue around the vagina (i.e., vaginal redness) and, similarly, used percentage of
opening for each treatment condition. Bonferroni correction was used as a post-hoc
analysis.
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CHAPTER IV
RESULTS
The total number of animals in each condition ranged from 5 to 12 (PNA-CORT:
n = 12; PNA-Control: n = 9; Prenatal Saline-CORT: n = 5, and Prenatal Saline-Control: n
= 11). There was a non-significant trend for fewer female pups in DHT-treated (M = 3.5,
SD = 1.38) compared to prenatal saline-treated (M = 5.33, SD = 1.53) litters, t(7) = 1.83,
p = .056. As a reminder, litters were collapsed within each pair housed cage of dams.
Data for body weights, vaginal openings/vaginal redness, anogenital distances, forced
swim immobility, and time spent in the open arms and total arm entries in the EZM are
discussed below.
Body Weight
PNA and prenatal saline pups were not significantly different in body weight
before weaning an analyzed by a 2 (PNA, Prenatal Saline) x 3 (PN7, PN14, PN21)
ANOVA; however, there was a significant main effect of PN day, F(2, 14) = 44.71, p
< .001, with a post-hoc comparison indicating that body weights increased significantly
across days, ps < .05, as shown in Table 1. Body weights were also collected daily after
pellet implantation and the average body weight across those days was analyzed via a 2
(PNA, Prenatal Saline) x 2 (CORT, Control) ANOVA, which found no significant effects
or interaction, as shown in Figure 1. For body weight at euthanasia, the prenatal condition
did not significantly affect body weight, but postnatal pellet implantation did significantly
influence body weight, F(1, 33) = 5.22, p < .05, with the CORT condition having lower
body weights as shown in Table 2.
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Table 1
Average Female Body Weights (g) at PN7, PN14, and PN21
Group

n

PN7

PN14

PN21

M (SD)

M (SD)

M (SD)

PNA

21

4.94 (2.45)

7.22 (1.21)

8.33 (1.64)

Prenatal- Saline

16

4.60 (1.72)

6.84 (0.73)

8.15 (0.92)

Table 2
Average Body Weights (g) at Time of Euthanasia
n

M (SD)

PNA-CORT

12

17.67 (0.68)

PNA-Control

9

18.33 (0.72)

Prenatal Saline-CORT

5

17.52 (1.23)

Prenatal Saline-Control

11

18.45 (0.93)

Body Weight (g)

Group

19
18.5
18
17.5
17
16.5
16

*

CORT

Control
Postnatal Treatment

Figure 1. Average body weights (g ± SEM) at time of euthanasia collapsed across
prenatal conditions. *Difference between CORT and control, p < .05.
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Vaginal Openings
An ANOVA for the factor of prenatal treatment on vaginal opening did not reveal
any differences. However, PNA mice showed vaginal redness in some cases, as described
previously, instead of vaginal opening. If the redness were coded as the day of vaginal
opening, then prenatal treatment did significantly affect vaginal opening (i.e., vaginal
redness), F(1, 35) = 6.04, p < .05, as shown in Figure 2. Of the PNA mice, 50% showed
vaginal opening or vaginal redness at day 4, whereas 50% of prenatal saline mice showed
vaginal opening later at day 8. At day 8, 100% of PNA mice showed vaginal opening or
vaginal redness, whereas prenatal saline mice reached 100% vaginal opening at day 13.

Percentage of Subjects

120
100
80
60
PNA

40

PrenatalSaline

20
0
1

2

3

4

5

6

7

8

9 10 11 12 13

Postnatal Day After Weaning
Figure 2. Percentage of subjects on each post-weaning day showing vaginal opening or
vaginal redness (for PNA subjects); differences between PNA and prenatal saline as
noted in text.
Anogenital Distance
A 2 (PNA, Prenatal Saline) x 2 (CORT, Control) ANOVA for anogenital distance
immediately after euthanasia revealed a significant effect of prenatal treatment, F(1, 29)
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= 6.79, p < .05, but no effect of postnatal manipulation nor an interaction. PNA mice had
significantly longer anogenital distances than prenatal saline mice, as detailed in Table 3.
Data is collapsed within prenatal treatment groups (i.e., PNA and Prenatal Saline).
Table 3
Average Anogenital Distance (mm) at Euthanasia
Group

n

M (SD)

PNA

20

5.9 (1.0)

Prenatal-Saline

13

5.0 (0.4)

EZM and Anxiety-like Behavior
Time Spent in the Open Arms. Outliers, represented by scores greater or less
than two standard deviations from the mean of each condition, were removed prior to
analysis, resulting in n = 10, n = 7, n = 5, and n = 9 for the PNA-CORT, PNA-Control,
Prenatal Saline-CORT, and Prenatal Saline-Control conditions, respectively.
A 2 (PNA, Prenatal Saline) x 2 (CORT, Control) x 5 (1-5 min) ANOVA revealed
a significant main effect of test minute on time spent in the open arms, F(4, 108) = 3.42,
p < .05, in addition to a test minute x prenatal treatment interaction, F(4, 108) = 2.71, p
< .05. A post-hoc comparison of the interaction revealed no differences among prenatal
conditions at any specific test minute but did reveal that time spent in the open arms
increased significantly from test minute 2 to test minute 3 and from test minute 3 to test
minute 4, ps < 0.05, as detailed in Table 4. Follow up ANOVAs were conducted for the
factors of prenatal and postnatal treatments at each of the 5 test minutes, with only test
minute 4 yielded a significant difference between prenatal treatments, F(1, 29) = 314.08,
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p < .05. PNA subjects showing increased time spent in open arms of the maze. Mean and
standard deviations collapsed across postnatal treatment conditions into PNA and
prenatal saline groups, M = 11.53, SD = 7.5, and M = 5.56, SD = 6.3, respectively.
Table 4
Time Spent in Open Arms (sec) in the EZM by Test Minute and Group
Groups

n

Minute 1 Minute 2 Minute 3

Minute 4

Minute 5

M (SD)

M (SD)

M (SD)

M (SD)

M (SD)

PNA-CORT

10

3.6 (6.3)

2.9 (4.1)

6.2 (6.7)

9.0 (9.2)

6.9 (6.2)

PNA-Control

7

5.5 (5.0)

3.6 (4.0)

4.2 (7.2)

14.4 (5.8)

5.0 (2.5)

Prenatal Saline-CORT

5

3.4 (5.5)

4.7 (7.2)

4.8 (6.2)

8.4 (7.5)

13.3 (9.0)

Prenatal Saline-Control

9

4.6 (6.1)

4.1 (5.2)

8.8 (7.9)

2.8 (3.6)

7.5 (7.4)

Total Entries into Arms. Analysis of total entries into arms on the EZM did not
reveal any significant effects of prenatal or postnatal treatments nor on test minute on the
apparatus as partially depicted in Table 5.

32

Table 5
Total Entries into Open and Closed Arms on the EZM
Groups

n

Open Arms Entries

Closed Arms Entries

M (SD)

M (SD)

PNA-CORT

10

7.1 (4.2)

6.8 (4.6)

PNA-Control

7

7.0 (2.6)

6.2 (2.8)

Prenatal Saline-CORT

5

5.6 (2.2)

4.9 (2.4)

Prenatal Saline-Control

9

4.8 (2.6)

4.9 (2.8)

Forced Swim Test: Depression-like behavior
Outliers, represented by scores greater or less than two standard deviations from
the mean of each condition, were removed prior to analysis, resulting in n = 9, n = 7, n =
4, and n = 11 for the PNA-CORT, PNA-Control, Prenatal Saline-CORT, and Prenatal
Saline-Control conditions, respectively.
A mixed 2 (PNA, Prenatal Saline) x 2 (CORT, Control) x 5 (1-5 min) ANOVA
for immobility on the forced swim test revealed a significant main effect of test minute,
F(4, 108) = 104.43, p < .001; post-hoc comparisons revealed increases in immobility
across the test such that test minute 1 had less immobility than test minutes 2-5 and test
minute 2 had less immobility than test minutes 3-5, ps < .001, as detailed in Table 6.
There was also a significant effect of prenatal manipulation, F(1, 27) = 9.30, p < .01, with
PNA animals having lower immobility than prenatal saline animals, as depicted in Figure
3. Prenatal manipulation for the total time spent immobile is collapsed across postnatal
treatments, for example, PNA-CORT and control treatments combined and prenatal
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saline-CORT and control treatment (M = 19.25, SD = 12.26 and M = 27.79, SD = 14.54,
respectively).
Table 6
Immobility Time (sec) by Test Minute and Group on the Forced Swim Test
Groups

n

Minute 1

Minute 2

Minute 3

Minute 4

Minute 5

M (SD)

M (SD)

M (SD)

M (SD)

M (SD)

PNA-CORT

9

1.4 (1.5)

14.2 (4.7)

22.1 (5.0)

25.1 (6.4)

26.7 (9.0)

PNA-Control

7

1.9 (1.5)

14.7 (7.2)

23.8 (11.8) 33.7 (7.3)

30.7 (6.7)

Prenatal

4

4.1 (1.7)

22.3 (9.2)

35.0 (5.6)

36.1 (9.9)

31.4 (5.5)

11

2.3 (1.4)

18.6 (9.6)

31.5 (9.6)

33.1 (10.4) 36.2 (8.2)

Saline-CORT
Prenatal

Immobility (sec)

160
140
120
100
80
60
40
20
0

*

Saline-Control

PNA

Prenatal-Saline
Prenatal Treatment

Figure 3. Time (sec  SEM) spent immobile in the forced swim test by prenatal condition.
Prenatal condition (PNA or Prenatal-Saline) is collapsed across postnatal stress (CORT
or control) conditions. *Difference between PNA and prenatal saline animals, p < .01.
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CHAPTER IV
DISCUSSION
In the current study, the PNA model resulted in decreased anxiety-like (i.e.,
increased time in the open arms on the EZM at test minute 4) and depression-like (i.e.,
decreased time spent immobile in the forced swim test) behavior. Neither decreased
anxiety-like behavior on the elevated zero maze nor, decreased depression-like behavior
on the forced swim test was expected in PNA mice. Effects of the prenatal model were
observed on the physiological measures of vaginal redness and anogenital distance with
earlier vaginal redness and longer anogenital distances in PNA mice compared to saline
controls. The postnatal treatment also altered body weight at the time of euthanasia, with
animals who were implanted with a CORT pellet having lower body weight than animals
implanted with a control pellet. Applications of the current findings to future research
will be important for understanding the interconnections between PCOS and mental
illness. In addition, limitations of the current study may be overcome in future research.
PNA Model and Anxiety-like behavior
As noted, PNA-treated mice showed decreased anxiety-like behavior during the
4th minute of the EZM test and did not alter activity levels as measured by total arm
entries. These findings do not support the hypothesis that our PCOS model or our
postnatal stress condition would result in increased anxiety-like behavior. Given that
prior research has demonstrated the EZM to be a sensitive measure for anxiety-like
behavior in rodents (Bell et al., 2014), it might be argued that the current prenatal PCOS
model did not alter anxiety-like behavior. Our prenatal PCOS and stress manipulations
did not impact anxiety-like behavior as expected. The lack of expected findings may be
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due to differences in lab protocols for measuring anxiety-like behavior (i.e., different
anxiety-like testing procedures).
As previously noted, Ressler et al. (2015) found total percent time spent in the
open arms to be significantly different between control and DHT-treated animals on the
EZM, supporting a conclusion of increased anxiety-like behavior in a PCOS animal
model. The contradictory findings in the current study may be due to differences in the
timing of DHT treatment (i.e., postnatal vs. prenatal, respectively) between Ressler et
al.’s study and the current research. The etiology of anxiety and depression in PCOS
might not be due to developmental factors but, instead, to environmental or epigenetic
changes that occurs after birth, allowing Ressler et al. (2015) to find changes in his
postnatal model because elevating testosterone levels postnatally have a stronger impact
on the stress system and, subsequently, on anxiety-like behavior.
The EZM analysis only coded the total amount of time spent in the open arms and
the number of total arm entries. However, exploratory behavior on the EZM may also
provide useful measures of anxiety-like behavior (Rodgers, Cao, Dalvi, & Holmes, 1997).
Commonly reported exploratory behaviors include head dips (i.e., looking over the side
of the maze) and stretch-attend posture (i.e., extended posture and minimal movement;
Molewijk, van der Poel, & Olivier, 1995). For example, protected-head dipping and
sniffing in the closed area, in a factor analysis, loaded highly with anxiety (Rodgers et al.,
1997). Another study found that a dose of the anxiolytic drug, diazepam, increased the
number of open arm entries as well as head dips in the open areas but decreased the
frequency of stretch-attend postures (Matto, Harro, & Allikmets, 1997). Thus, head dips
in the open arms might be interpreted as decreased anxiety-like behavior, but increased
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stretch-attend postures and closed-arm head dipping might indicate increased anxiety-like
behavior (Rodgers et al., 1997). Studying exploratory behaviors may provide more
nuanced measures of anxiety-like behavior in rodent models and, therefore, future studies
should consider coding these measures.
PNA Model and Depression-like Behavior
Behavior on the forced swim test in the current study aligned with prior reports of
increased immobility across time on this behavioral test (Petit-Demouliere, Chenu, &
Bourin, 2005). With approximately 4,300 published papers using the forced swim test, it
appears to be a popular measure for depression-like behavior (Molendijk & de Kloet,
2015). Despite the ubiquitous use of the forced swim test, neither prenatal nor postnatal
manipulations associated with DHT and CORT, respectively, changed immobility as
expected in the current study. In fact, contrary to our expectation, PNA mice showed
lower immobility than prenatal saline controls (i.e., less depression) while our postnatal
manipulation did not have any effects on immobility.
Previous studies have found increased immobility in postnatal models of PCOS
(Yu et al., 2016), suggesting that, similarly to our findings regarding anxiety-like
behavior, postnatal but not prenatal DHT treatment may yield PCOS models that more
strongly impact behavior. Yu et al. (2016) also correlated changes on their behavioral
tests to decreased levels of dopamine, serotonin, and norepinephrine in their DHT-treated
animals, indicating potential neurochemical mechanisms that could underlie the observed
behavioral changes. Using measures of neurotransmitter function may be particularly
relevant as a biological endpoint and collecting brain tissue samples in a prenatal model
of PCOS may be an important step in the development of PCOS animal models. The
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majority of PCOS research focuses on metabolic features of the disorder and examining
psychological components of the disorder in animals remains a novel and relatively
recent pursuit, resulting in limited information on brain-related changes. Investigating
changes in neurochemistry would be an important step to understanding the etiology of
depression or other mental illness in PCOS.
A recent publication further complicates our ability to interpret the current
findings in that that article calls into doubt the use of the forced swim test as a true
measure of depression-like behavior (Molendijk & de Kloet, 2015). According to those
authors, the forced swim test more accurately represents a response to an acute stressor
(i.e., rodent being placed in water they cannot escape) than a test of depression-like
behavior. Thus, our mice may actually be demonstrating dampened stress reactivity in the
PNA conditions similar to those described by Ressler et al. (2015) in women with PCOS.
If the DHT prenatal treatment does decrease stress reactivity, then we would expect to
see an increase in mobility (i.e., less depression-like behavior) compared to prenatal
saline controls which was observed in the current study.
Applying this argument provides an explanation for the contradictory findings
between the current study and previous work, and further suggests that future
assessments of psychological and/or behavioral changes in animal models of PCOS
might consider utilizing different tests to measure depression-like behavior. One example
of an alternative test for depression-like behavior is the sucrose preference test. Snyder,
Soumier, Brewer, Pickel, & Cameron (2012) used a stress paradigm, not related to a
PCOS model, and examined depression-like behavior using the forced swim and sucrose
preference test; finding changes in depression-like behavior on both tasks. The sucrose

38

preference test is based on anhedonia, or lack of enjoyment from activities, which is a
common symptom of depression. In a similar vein, Kim, Yang, Kwon, Woo Lee, and
Kim (2017) used an unpredictable shock stressor and found that the sucrose preference
test showed changes in anhedonia-like behavior that were not visible in the forced swim
test. Thus, sucrose preference tests may allow researchers to study other depression-like
symptoms (i.e., anhedonia or lack of pleasure) in animal models and using a test with
construct validity for depression-like behavior may provide a more accurate assessment
of the effects of PCOS models.
PNA model
In the current study, our PNA model resulted in a narrow change in anxiety-like
behavior that was not in the anticipated direction and a change in depression-like
behavior that was contrary to prior findings. The PNA model also resulted in increases in
anogenital distance and qualitative differences in sexual maturity as measured by vaginal
redness, indicating that physiological changes were associated with the prenatal treatment.
Future studies might consider more thoroughly evaluating the redness and vaginal fusion
present in PNA mice. Alternatively, another measure related to sexual maturity is the
estrous cycle, which can provide biological information about the hormones present at
different stages of the cycle (Caligioni, 2009). For example, Caldwell et al. (2014)
reported that PNA mice completed fewer estrous cycles. Anogenital distance is another
revealing measure used in PCOS models because female rodents treated with testosterone
should show longer anogenital phenotypes (Wu et al., 2017) as observed in the current
study.
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As a model of PCOS, prenatal treatments have been well studied in regard to
physiological phenotypes in animal models, while investigations of anxiety- and
depression-like behavior are largely understudied. Thus, it may also be important to
include estrous cycle information is order to ensure hormonal changes are not impacting
behavior on tests like the EZM or forced swim test. Meziane, Ouagazzal, Aubert,
Wietrzych, and Krezel (2007) used a battery of behavioral tests to compare strain and
estrous cycle differences on behavior and found their largest differences on a despair-like
behavioral test similar to the forced swim test. In particular, C57BL/6J mice showed
increased immobility on the despair-like behavioral test while in the stage of metestrous.
Thus, potential effects of estrous cycle stage on behavioral measures may be especially
important to evaluate in a PCOS model, which is known to impact hormone regulation
and estrous cycle. Measuring estrus cycle could also help to identify the acyclicity often
found in models of PCOS. Ovarian measures (i.e., ovarian weight and presence of cysts)
are also commonly reported as physiological properties of PCOS models (i.e., Caldwell
et al., 2014; Walters et al., 2012) and future research could include ovarian measures to
evaluate prenatal PNA models for both behavior and physiological changes.
PNA and Stress
As mentioned previously, prenatal exposure to DHT as a model for PCOS
resulted in narrow and contradicting differences in behavior on the EZM; as such, it is
interesting to consider the interplay of the PNA and CORT treatments. Ressler et al.
(2015) discussed how DHT treatment resulted in a dampened CORT response during
novel environment exposure. That finding was not replicated in the current study,
because if PNA were to dampen reactivity to CORT, then it would be expected that
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CORT pellet implantation in DHT-treated animals would result in increased time spent in
the open arms due to less fear or anxiety. These scenarios present the plausibility that the
complex interaction between CORT and PNA treatment is more complex than a test such
as the EZM can unmask. Moreover, an important aspect in understanding the interplay of
PNA and CORT is to analyze CORT serum levels. Performing this serum analysis might
help in understanding the difference in CORT reactivity in models of PCOS.
Behavioral findings from our prenatal PCOS model support further study into
behavioral differences using other anxiety- and depression-like tests. It is likely that the
depression experienced in women with PCOS arises from hormonal dysfunction and
alterations to the HPA axis which have been found in some people with depression
(Varghese & Brown, 2001). In particular, the dexamethasone suppression test (i.e., Carrol
et al., 1982) show that a subset of individuals with depression respond abnormally to
administration of the synthetic cortisol and do not decrease their own endogenous cortisol
production. Importantly, depression resulting from dysfunctional neuroendocrine systems
has not been validated in classical behavioral tests like the forced swim test which should
be a consideration when selecting behavioral tests in PCOS rodent models.
Genetic factors have been found that influence the connection between stress and
mental illness. A longitudinal study by Capsi et al. (2003) found that some participants
with depression also had a serotonin transporter allele variant that altered the functioning
of serotonin, a neurotransmitter related to depression. In their study, life stress events
were measured and correlated with the allele variant, and the authors concluded that the
interaction of stress with this genetic polymorphism enhanced the development of mental
illness (Capsi et al., 2003). In a meta-analysis evaluating depression and stress, Karg,
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Burmeister, Shedden, and Sen (2011) found strong connections between the same allele
described by Capsi et al. (2003) and stress and depression. Thus, genetic variability
among women with PCOS or between animal strains used in PCOS models may
influence the appearance of anxiety- or depression-like behaviors.
If the depression observed in women with PCOS results from an underlying
physiological basis rather than from sociocultural stressors, then hormone alterations may
underpin depression in these women and classic behavioral tests for depression-like
behavior in mice may not be sensitive models for this type of depression. To note, the
tests used in the current research do have predictive validity in pharmaceutical research
but, as a result, may not have generalizability when applied to circumstances other than
that associated with monoamine-altering antidepressants (Petit-Demouliere, Chenu, &
Bourin, 2005). As mentioned previously, other tests such as the sucrose preference test
could add complexity and accuracy to the depression-like behaviors measured in rodent
models.
Validating the Physiological Model
This study is in agreement with previous reports that body weight does not
increase in PNA mice either prior to weaning or during young adulthood (i.e., Caldwell et
al., 2014; Roland et al., 2010; Walters et al., 2012), although these findings do contrast
with a report from Caldwell et al. (2014) of increased weight gain in a postnatal model of
PCOS. For example, in examining animals at 3, 4, and 5 months of age (i.e., later ages
than measured in the current study), Roland and colleagues (2010) did not report weight
differences in a prenatal PCOS model. One explanation for the lack of weight differences
in prenatal PCOS models may be based on reabsorption that occurs in rodents to optimize
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survival of offspring. Jafari et al. (2017) examined reabsorption rates in C57Bl/6J mice
exposed to an auditory stress and found dams to have higher levels of reabsorption and
fewer birthed pups. If the prenatal DHT treatment were a perceived stressor, either
physiologically or environmentally, those mice of a lower fetal weight may have
undergone reabsorption, with the remaining offspring displaying higher resiliency to
environmental or physiological stressors. As we see a trend towards smaller DHT litters
this could be an important consideration.
CORT treatment decreased body weight in the current study. Because stress
responses involve the body diverting energy to the sympathetic system and away from
functions like building body weight, it would be expected that subjects in the stress
condition weighed less than controls (Divyashree & Yajurvedi, 2016) although a lack of
body weight differences following CORT pellet implantation has been reported (Sturm et
al., 2015). CORT serum level analysis will be undertaken on samples collected during the
current study and are expected to confirm higher CORT levels in those mice implanted
with CORT pellets as observed by Sturm and colleagues’ (2015). Future research should
verify serum CORT levels from pellets. Understanding and measuring these specific
changes are necessary for further validating the CORT treatment.
Limitations
Several limitations to this study were identified upon completion. There were a
restricted number of prenatal saline subjects due to small litter sizes in saline-treated
dams. Due to multiple within subject ANOVA analyses, inherent type I error is probable
(i.e., false-positive) and explains the marginal change in decreased anxiety-like behavior
in PNA mice at minute 4 on the EZM. This difference in anxiety-like behavior could be
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produced by this false-positive result. Nonetheless, the ANOVA tests were used
appropriately and the type I error or alpha inflation is a result of the test itself. Large
differences in scores were also found in minute 4 of the elevated zero maze. Another
limitation occurred due to difficulties in coding the videos from the forced swim test due
to low room lighting, which were reduced because Huang, Zhou, and Zhang (2012)
identified changes in anxiety-like behavior and performance on the Morris Water Maze in
reaction to bright lighting conditions. Based upon these prior findings and in order to
prevent overhead lights from altering behavior, the light in our testing room was
decreased which, unfortunately, resulted in poor video quality for the forced swim test.
Future research
Several suggestions regarding future research have already been made. To
reiterate, for the EZM, future research should consider including coding exploratory
behaviors for a potentially more robust measure of anxiety-like behavior. As for the
forced swim test and depression-like behavior, it may be important to include other
behavioral assays; for example, the sucrose preferences test. As well, the importance of
measuring neuronal tissue in relation to behavioral changes would be an important
physiological end point. The confirmation of vaginal redness as a measure of vaginal
opening in PNA mice would also be important, as would measures of estrous cycle and
ovarian morphology for validating the PNA model. Furthermore, estrous cycle measures
may be important in enhancing our understanding of behavior variations on the EZM
and/or forced swim test and could potentially allow us to unmask differences due to
prenatal or postnatal treatments.
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Another important area of PCOS research, which remains unexplored, involves
examining the impact of prenatal DHT treatment on male offspring behavior. Only
female offspring were used in the current study; however, there may be changes to PNA
males as well. Male offspring from the treated dams were also run on behavioral testing
and analysis will be done in the future. Elevated in utero testosterone was shown, in a
study comparing women with and without PCOS, to increase androstenedione in male
and female offspring (Daan, Koster, Steegers-Theunissen, Eijkemans, & Fauser, 2017).
Moreover, offspring from women with PCOS showed that elevated levels of testosterone
impacted androgen hormone levels in their offspring. A related study found that male rats
exposed to prenatal testosterone showed increased hypertension features later in life
(Chinnathambi, Balakrishnan, Yallampalli, & Sathishkumar, 2012). Male offspring that
have experienced an elevated testosterone environment in utero also demonstrate higher
levels of testosterone in adulthood when compared to controls (as cited in Chinnathambi
et al., 2012). Lastly, in a study using male sheep as a model of elevated in utero
testosterone, altered responsiveness of hormones for gonadal development and regulation
was found (i.e., gonadotropin-releasing hormone; Recabarren et al., 2012). These
findings indicate that male reproductive systems show abnormalities following elevated
prenatal testosterone, and, thus, it may be useful to explore behavioral changes in males
exposed to our prenatal PCOS model.
Studies on carryover effects in behavioral testing have yielded mixed results
across various tests and rodent models. Blokland et al. (2012) found that the forced swim
test was more sensitive than the EZM to testing history in rats, which would indicate that
the opposite order should have been employed in the current study. However, the forced
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swim test was the only assay for which Blokland et al. controlled the ordering of testing,
limiting the applicability of their findings. Future research may find differences if they
staggered the order of EZM testing. Alternatively, testing order may not have impacted
behavior in the current study; McIlwain et al., (2001) found that mice showed similar
behavior in the open-field test regardless of testing history. Given that either our prenatal
or postnatal manipulations may have altered animal sensitivity to the behavioral tests, it
may be useful to investigate order of testing effects in future PCOS research.
Conclusion
The prenatal model of PCOS used in the current research attempted to examine
changes in anxiety- and depression-like behaviors. In addition to the standard prenatal
model of PCOS, a stress condition was induced to more accurately model the human
experience of PCOS. Behavioral tests were used to analyze differences due to the
prenatal model of PCOS and the postnatal stress manipulation. Behavioral differences
were found in both the EZM and forced swim test, with decreased anxiety-like behavior
found in one of the five minutes of testing on the EZM and decreased depression-like
behavior found in PNA as compared to prenatal saline mice. Differences were also found
in physiological measures, including anogenital distance, body weight, and vaginal
redness that are consistent with what was expected for our prenatal and postnatal
treatments. Modeling PCOS in animal models is crucial to creating a better understanding
of the etiology, biological mechanisms, and potential treatments for this syndrome.
Women with PCOS suffer from various metabolic and reproductive difficulties, including
increased risk of diabetes, obesity, infertility, and ovarian cysts. Not only do women with
PCOS suffer from physical symptoms associated with the disorder but they also have an
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increased risk for developing mental illness. Thus, it remains essential to research the
connections between PCOS and mental health in order to create better treatments.
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Appendix A
Behavioral Assays Used for Depression- and Anxiety-like Behavior
Elevated zero maze

Forced swim test

59

